Enko

Enko

Private
Mystic, ConnecticutFrontier & Industrial Techhttps://www.enko.ag

Last Round

Series C

Jan 31, 2023

Est. Valuation

$320M

Total Funding Raised

$216M

Momentum Score

25 /100

Company Overview

Enko is an agricultural technology company that develops safe and sustainable small molecule solutions to help farmers protect their crops from pests and diseases.

Sector

Frontier & Industrial Tech

Verticals

Drug Discovery, Biotechnology, ML Platforms

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Infrastructure

Keywords

crop protectionAgTechDNA-encoded librariesAI for agriculturesmall molecule discoveryherbicidesfungicidesAI discovery platformagrochemical discoveryweed controlpest resistancetarget-based discoverysustainable agricultureR&D partnershipssmallholder farmer solutions

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Enko Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Enko Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CJan 31, 2023
Series CJul 27, 2022
Series BJun 26, 2020

Key People

Founding team and executive leadership

Anthony Klemm

Chief Executive Officer

Executive Team

Enko Investors

Notable investors and investment history

InvestorRounds
Eight Roads VenturesSeries C
Germin8 VenturesSeries B, Series C
Anterra CapitalSeries B, Series C, Seed
Endeavor8Series C
Bill & Melinda Gates FoundationSeries C
The Bill & Melinda Gates Foundation TrustSeries C, Series B
Novalis LifeSciencesSeries B, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Partnerships with Syngenta and Bayer disclosed in job posting.

  • Jan 21, 2025

    Added ZAGENO Inc., an AgTech/Biotech company, as a customer.

Enko Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Enko Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Enko's valuation, stock price, and market status.

Firmographic Details

HeadquartersMystic, Connecticut
Employee Range56
Year Founded2017
Last FundingJan 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.